Form 4 for GILD Gilead Sciences
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001127602-21-029042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-12 | 2021-11-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | +5,100 | 19.2K | +36% | — |
| D | 2021-11-12 | 2021-11-10 | GILD | Parsey Merdad | Chief Medical Off | F - Tax | $67.32 | -2,320 | 16.9K | -12% | -$156.2K |
| D | 2021-11-12 | 2021-11-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | -5,100 | 32.1K | -14% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | M | A | 5,100 | — | 19,180 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2021-11-10 | F | D | 2,320 | $67.32 | 16,860 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2021-11-10 | M | D | 5,100 | — | 32,089 | D | — · — to — | 5,100 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. |